Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Exercise/Conversion of 8,750 AQST shares, $23.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Aquestive Therapeutics, Inc. (AQST) | Exercise/Conversion | 8,750 | $23.2K |
| Aug 17, 2026 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 2,714 | $11.5K |
| Jun 9, 2026 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 2,714 | n/a |
| Apr 13, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 67,500 | n/a |
| Mar 11, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 75,000 | n/a |
| Aug 15, 2025 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 25,000 | n/a |
| Jun 10, 2025 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 2,714 | $9.6K |
| Mar 11, 2025 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 90,000 | n/a |
| Jun 11, 2024 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 25,000 | n/a |